Elevar Therapeutics Competitors and Similar CompaniesClear all
Elevar Therapeutics's competitors and similar companies include DAVA Oncology, PLIVA, Takeda and Pharmacyclics.
 Elevar Therapeutics Elevar Therapeutics (previously known as LSK BioPharma) is a pharmaceutical company. |  DAVA Oncology DAVA Oncology is a company that provides solutions and services to the pharmaceutical and biotechnology industries aiming to support cancer drug development. |  PLIVA PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products. |  Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. |  Pharmacyclics Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. | |
Founding Date | Founding Date 2005 | Founding Date 2007 | Founding Date 1921 | Founding Date 1781 | Founding Date 1991 |
Type | Type Private | Type Private | Type Subsidiary | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations South San Francisco, US HQ Dublin, IE Salt Lake City, US | Locations Dallas, US HQ | Locations Zagreb, HR HQ Sarajevo, BA Skopje, MK Belgrade, RS | Locations Sunnyvale, US HQ | |
Employees | Employees 565% decrease | Employees 823% increase | Employees 1,685 | Employees 47,4554% decrease | Employees 6551% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥4.6t (FY, 2025) | Revenue (est.) $729.7m (FY, 2014) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥818.8b (FY, 2025) | Cost of goods $40.4m (FY, 2014) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit ¥3.8t (FY, 2025) | Gross profit $689.3m (FY, 2014) |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income ¥108.1b (FY, 2025) | Net income $86.1m (FY, 2014) |
Funding | |||||
Total funding raised | Total funding raised $ 20m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 57.8m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
DAVA Oncology
HQ
Dallas, US
Employees
82↑ 3% increase
DAVA Oncology is a company that provides solutions and services to the pharmaceutical and biotechnology industries aiming to support cancer drug development.
View companyPLIVA
HQ
Zagreb, HR
PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products.
View companyTakeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View companyPharmacyclics
HQ
Sunnyvale, US
Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.
View company